SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

A sharp rebound is drawing attention to NASAs CLPS 2.0 lunar-delivery program and the prospect of future task orders for Intuitive Machines, alongside anticipation of upcoming earnings. Traders are debating whether the companys eligibility to compete will translate into meaningful awards, while some attribute the bounce to short covering.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys engine, technology-licensing and engineering agreement with AST SpaceMobile for its planned rocket is driving attention, with traders viewing the deal as validation of Fireflys propulsion business and a boost to its backlog. Some are cautious about the stock component and financing details, execution risks, and the upcoming earnings report.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is drawing attention ahead of its earnings report, with traders focused on whether AI data-center networking demand can offset weaker or delayed traditional network refresh spending; guidance and margins are a key point of debate. The recent selloff and analyst caution have frustrated bears and holders, while some traders see AI infrastructure demand as a reason to buy the dip.

GLOBALFOUNDRIES, Inc. provides foundry services and manufactures semiconductors. It offers global shuttle, mask, post-fab and turnkey services. The company was founded on October 7, 2008 and is headquartered in Malta, NY.

GlobalFoundries Inc

GlobalFoundries recent earnings beat and stronger profit guidance are drawing attention, but shares have remained volatile amid analyst price-target cuts and bearish options positioning. Traders are split between concerns about mature-node demand and contract renewals, and the view that the selloff is overdone and the results support a rebound.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Analyst upgrades and Zeta Live announcements are driving attention: traders are weighing Goldman Sachs Buy upgrade and optimism around the new AthenaOS platform and AI partnerships against questions about execution and whether the products will translate into revenue. Many are positioning ahead of earnings, while others are cautious about the stocks ability to sustain its gains amid broader tech-market weakness.

Bicara Therapeutics, Inc. is a clinical-stage biotechnology company and develops biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor microenvironment modulators. The company’s bi-functional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Its products include BCA101, a first-in-class EGFR/TGF-ß-trap bifunctional antibody in clinical development for multiple tumor types. The company was founded on December 12, 2018 and is headquartered in Boston, MA.

Bicara Therapeutics Inc.

Bicara Therapeutics

Bicara shares are being discussed in the wake of positive Phase 3 results from competitor Genmab, which traders believe raised competitive concerns for Bicaras head-and-neck cancer drug and contributed to a sharp selloff. The community is split between viewing the decline as justified by the competitive threat and calling it an overreaction, with bullish posters pointing to Bicaras differentiated therapy and upcoming pivotal-trial data.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubriks strong quarterly results and raised full-year outlook have drawn attention, but shares sold off as traders questioned the slower cloud net-new ARR outlook and managements guidance. Bulls view the business and AI-related cyber-resilience demand as intact, while skeptics argue that high expectations and management credibility concerns could keep pressure on the stock.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemons steep decline and Michael Burrys reported exit of his position for tax-loss reasons dominate discussion, alongside concerns about weakening demand, competition, and the companys turnaround. Traders are split between viewing the selloff and Burrys departure as further downside signals and seeing the beaten-down valuation and new leadership as potential reasons for a rebound.

Chainlink (LINK) is a cryptocurrency launched in 2017and operates on the Ethereum platform. Chainlink has a current supply of 1,000,000,000 with 748,099,970.42488396 in circulation. The last known price of Chainlink is 10.7808229 USD and is down -0.30 over the last 24 hours. It is currently trading on 2314 active market(s) with $147,808,096.15 traded over the last 24 hours. More information can be found at https://chain.link/.

ChainLink

LINKs sharp rebound and breakout have drawn attention, with traders connecting the move to institutional and tokenization developments, including Coinbases reported selection of Chainlink infrastructure for tokenized stocks on Base. Bulls view adoption as a long-term tailwind, while skeptics question whether that utility will translate into token value and warn the rally could fade.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on the upcoming Q3 results and whether BRIUMVIs commercial growth is continuing; traders also view the subcutaneous Phase 3 readout as a key longer-term catalyst. Bulls point to sales momentum and possible short-covering or a buyout, while skeptics warn that expectations are elevated and the earnings reaction could be volatile.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


manahilkhan

Manahil Khan